549 related articles for article (PubMed ID: 23208835)
41. Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials.
Vieta E; Günther O; Locklear J; Ekman M; Miltenburger C; Chatterton ML; Åström M; Paulsson B
Int J Neuropsychopharmacol; 2011 Sep; 14(8):1029-49. PubMed ID: 21733231
[TBL] [Abstract][Full Text] [Related]
42. Adverse events in children and adolescents treated with antipsychotic medications.
Jerrell JM; McIntyre RS
Hum Psychopharmacol; 2008 Jun; 23(4):283-90. PubMed ID: 18302312
[TBL] [Abstract][Full Text] [Related]
43. Psychotropic medication changes, polypharmacy, and the risk of early readmission in suicidal adolescent inpatients.
Fontanella CA; Bridge JA; Campo JV
Ann Pharmacother; 2009 Dec; 43(12):1939-47. PubMed ID: 19934394
[TBL] [Abstract][Full Text] [Related]
44. Association between mood-stabilizing medication and mental health resource use in the management of acute mania.
Sajatovic M; Gerhart C; Semple W
Psychiatr Serv; 1997 Aug; 48(8):1037-41. PubMed ID: 9255836
[TBL] [Abstract][Full Text] [Related]
45. National estimates of the inpatient burden of pediatric bipolar disorder in the United States.
Berry EA; Heaton PT; Kelton CM
J Ment Health Policy Econ; 2011 Sep; 14(3):115-23. PubMed ID: 22116169
[TBL] [Abstract][Full Text] [Related]
46. [Child and adolescent bipolar disorder].
Aichhorn W; Stuppäck C; Kralovec K; Yazdi K; Aichhorn M; Hausmann A
Neuropsychiatr; 2007; 21(2):84-92. PubMed ID: 17640494
[TBL] [Abstract][Full Text] [Related]
47. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
48. National trends in the outpatient diagnosis and treatment of bipolar disorder in youth.
Moreno C; Laje G; Blanco C; Jiang H; Schmidt AB; Olfson M
Arch Gen Psychiatry; 2007 Sep; 64(9):1032-9. PubMed ID: 17768268
[TBL] [Abstract][Full Text] [Related]
49. Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents.
McIntyre RS; Jerrell JM
Arch Pediatr Adolesc Med; 2008 Oct; 162(10):929-35. PubMed ID: 18838645
[TBL] [Abstract][Full Text] [Related]
50. Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence.
Baldessarini R; Henk H; Sklar A; Chang J; Leahy L
Psychiatr Serv; 2008 Oct; 59(10):1175-83. PubMed ID: 18832504
[TBL] [Abstract][Full Text] [Related]
51. Prescribing patterns for treatment of pediatric bipolar disorder in a specialty clinic.
Potter MP; Liu HY; Monuteaux MC; Henderson CS; Wozniak J; Wilens TE; Biederman J
J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):529-38. PubMed ID: 19877977
[TBL] [Abstract][Full Text] [Related]
52. Combination treatment in bipolar disorder: a review of controlled trials.
Zarate CA; Quiroz JA
Bipolar Disord; 2003 Jun; 5(3):217-25. PubMed ID: 12780875
[TBL] [Abstract][Full Text] [Related]
53. Psychotropic use and risk of stroke among patients with bipolar disorders: 10-year nationwide population based study.
Wu CS; Wu KY; Lo YR; Huang YW; Tsai YT; Li Y; Tsai HJ
J Affect Disord; 2018 Jan; 226():77-84. PubMed ID: 28964996
[TBL] [Abstract][Full Text] [Related]
54. [Therapeutic management of bipolar disorder in France and Europe: a multinational longitudinal study (WAVE-bd)].
Bellivier F; Delavest M; Coulomb S; Figueira ML; Langosch JM; Souery D; Vieta E
Encephale; 2014 Oct; 40(5):392-400. PubMed ID: 25238903
[TBL] [Abstract][Full Text] [Related]
55. Treatment of Young People With Antipsychotic Medications in the United States.
Olfson M; King M; Schoenbaum M
JAMA Psychiatry; 2015 Sep; 72(9):867-74. PubMed ID: 26132724
[TBL] [Abstract][Full Text] [Related]
56. Comparative effectiveness of monotherapy with mood stabilizers versus second generation (atypical) antipsychotics for the treatment of bipolar disorder in children and adolescents.
Chen H; Mehta S; Aparasu R; Patel A; Ochoa-Perez M
Pharmacoepidemiol Drug Saf; 2014 Mar; 23(3):299-308. PubMed ID: 24459113
[TBL] [Abstract][Full Text] [Related]
57. Evaluating drug safety in children and adolescents with bipolar disorder.
Heaton PC; Garlick CM; Tran D
Curr Drug Saf; 2006 Aug; 1(3):307-18. PubMed ID: 18690942
[TBL] [Abstract][Full Text] [Related]
58. Diabetes mellitus risk for 102 drugs and drug combinations used in patients with bipolar disorder.
Nestsiarovich A; Kerner B; Mazurie AJ; Cannon DC; Hurwitz NG; Zhu Y; Nelson SJ; Oprea TI; Crisanti AS; Tohen M; Perkins DJ; Lambert CG
Psychoneuroendocrinology; 2020 Feb; 112():104511. PubMed ID: 31744781
[TBL] [Abstract][Full Text] [Related]
59. The use of mood stabilizers and atypical antipsychotics in children and adolescents with bipolar disorders.
Kowatch RA; DelBello MP
CNS Spectr; 2003 Apr; 8(4):273-80. PubMed ID: 12679742
[TBL] [Abstract][Full Text] [Related]
60. National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007.
Comer JS; Olfson M; Mojtabai R
J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1001-10. PubMed ID: 20855045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
